结肠镜后结直肠癌的研究现状及进展  

Research status and progress of post-colonoscopy colorectal cancer

作　　者：肖婉祎 何安琪[1] 刘刚[1] Xiao Wanyi;He Anqi;Liu Gang(Department of General Surgery,Tianjin Medical University General Hospital,Tianjin 300052,China)

机构地区：[1]天津医科大学总医院普通外科,天津300052

出　　处：《中华炎性肠病杂志（中英文）》2023年第2期180-185,共6页Chinese Journal of Inflammatory Bowel Diseases

摘　　要：结肠镜后结直肠癌(PCCRC)是一类与结肠镜检查技术密切相关的结直肠癌。结肠镜检查质量问题以及某些分子机制导致病变快速进展是PCCRC的重要病因。炎症性肠病(IBD)患者人群中PCCRC的发病率高于一般人群, 根据危险因素分层、制定个体化随访间期是降低IBD相关PCCRC发病风险的有效措施。本文主要介绍PCCRC的发病率、病因及致病过程, 对IBD相关PCCRC的有关研究进行总结讨论, 并进一步探讨降低PCCRC发病风险的措施。Post-colonoscopy colorectal cancer(PCCRC)is a type of colorectal cancer closely related to colonoscopy.The quality problems of colonoscopy and some molecular mechanisms leading to the rapid progression of lesions are important causes of PCCRC.The incidence of PCCRC is higher in patients with inflammatory bowel disease(IBD)than the general population.Stratification of risk factors and individualized follow-up intervals are effective measures to reduce the risk of IBD-associated PCCRC.In this paper,we mainly introduce the incidence,etiology and pathogenesis of PCCRC,summarize relevant studies on IBD-associated PCCRC,and further discuss how to reduce the risk of PCCRC.

关 键 词：结肠镜后结直肠癌 炎症性肠病 分子机制 结肠镜检查 

分 类 号：R735.34[医药卫生—肿瘤]